Literature DB >> 32556941

Common transcriptome, plasma molecules, and imaging signatures in the aging brain and a Mendelian neurovascular disease, cerebral cavernous malformation.

Janne Koskimäki1, Sean P Polster1, Yan Li1,2, Sharbel Romanos1, Abhinav Srinath1, Dongdong Zhang1, Julián Carrión-Penagos1, Rhonda Lightle1, Thomas Moore1, Seán B Lyne1, Agnieszka Stadnik1, Kristina Piedad1, Ying Cao1, Robert Shenkar1, Alexey V Dimov3, Nick Hobson1, Gregory A Christoforidis3, Timothy Carroll3, Romuald Girard1, Issam A Awad4.   

Abstract

Brain senescence is associated with impaired endothelial barrier function, angiogenic and inflammatory activity, and propensity to brain hemorrhage. The same pathological changes occur in cerebral cavernous malformations (CCM), a genetic neurovascular anomaly. We hypothesized common transcriptomic and plasma cytokine signatures in the aging brain and CCM. We identified 320 genes [fold change ≥1.5; p < 0.05; false discovery rate (FDR) corrected] commonly dysregulated in the aging brain and CCM. Ontology and pathway analyses of the common differentially expressed genes were related to inflammation and extracellular matrix organization. Plasma levels of C-reactive protein and angiopoietin-2 were significantly greater in older compared to younger healthy non-CCM subjects and were also greater in CCM (Sporadic and Familial) subjects regardless of age (all: p < 0.05; FDR corrected). Plasma levels of vascular endothelial growth factor were significantly greater in older compared to younger subjects, in both healthy non-CCM and Sporadic-CCM groups (all: padj < 0.05). Plasma levels of vascular endothelial growth factor were also significantly greater in Familial-CCM cases with germ line mutations regardless of age (all: padj < 0.05) compared to both healthy non-CCM and Sporadic-CCM subjects. Brain white matter vascular permeability assessed by MRI followed the same pattern as vascular endothelial growth factor across all groups. In addition, quantitative susceptibility mapping of brain white matter, a measure of iron deposition, was increased in older compared to younger healthy non-CCM subjects. Genetic aberrations, plasma molecules, and imaging biomarkers in a well characterized Mendelian neurovascular disease may also be applicable in the aging brain. Graphical abstract.

Entities:  

Keywords:  Background brain QSM; Background brain permeability; CCM disease; Neuro-vascular aging; Plasma biomarker; Transcriptome

Mesh:

Substances:

Year:  2020        PMID: 32556941      PMCID: PMC7525636          DOI: 10.1007/s11357-020-00201-4

Source DB:  PubMed          Journal:  Geroscience        ISSN: 2509-2723            Impact factor:   7.713


  40 in total

1.  The sva package for removing batch effects and other unwanted variation in high-throughput experiments.

Authors:  Jeffrey T Leek; W Evan Johnson; Hilary S Parker; Andrew E Jaffe; John D Storey
Journal:  Bioinformatics       Date:  2012-01-17       Impact factor: 6.937

2.  Synaptotagmin-mediated vesicle fusion regulates cell migration.

Authors:  Richard A Colvin; Terry K Means; Thomas J Diefenbach; Luis F Moita; Robert P Friday; Sanja Sever; Gabriele S V Campanella; Tabitha Abrazinski; Lindsay A Manice; Catarina Moita; Norma W Andrews; Dianqing Wu; Nir Hacohen; Andrew D Luster
Journal:  Nat Immunol       Date:  2010-05-16       Impact factor: 25.606

3.  Multiple hypothesis testing in proteomics: a strategy for experimental work.

Authors:  Angel P Diz; Antonio Carvajal-Rodríguez; David O F Skibinski
Journal:  Mol Cell Proteomics       Date:  2011-03       Impact factor: 5.911

4.  Immune complex formation and in situ B-cell clonal expansion in human cerebral cavernous malformations.

Authors:  Changbin Shi; Robert Shenkar; Andrew Kinloch; Scott G Henderson; Mark Shaaya; Anita S Chong; Marcus R Clark; Issam A Awad
Journal:  J Neuroimmunol       Date:  2014-05-10       Impact factor: 3.478

5.  Association Between Genetic Traits for Immune-Mediated Diseases and Alzheimer Disease.

Authors:  Jennifer S Yokoyama; Yunpeng Wang; Andrew J Schork; Wesley K Thompson; Celeste M Karch; Carlos Cruchaga; Linda K McEvoy; Aree Witoelar; Chi-Hua Chen; Dominic Holland; James B Brewer; Andre Franke; William P Dillon; David M Wilson; Pratik Mukherjee; Christopher P Hess; Zachary Miller; Luke W Bonham; Jeffrey Shen; Gil D Rabinovici; Howard J Rosen; Bruce L Miller; Bradley T Hyman; Gerard D Schellenberg; Tom H Karlsen; Ole A Andreassen; Anders M Dale; Rahul S Desikan
Journal:  JAMA Neurol       Date:  2016-06-01       Impact factor: 18.302

Review 6.  Circulating biologic markers of endothelial dysfunction in cerebral small vessel disease: A review.

Authors:  Anna Poggesi; Marco Pasi; Francesca Pescini; Leonardo Pantoni; Domenico Inzitari
Journal:  J Cereb Blood Flow Metab       Date:  2016-01       Impact factor: 6.200

7.  FcgammaRIIB mediates C-reactive protein inhibition of endothelial NO synthase.

Authors:  Chieko Mineo; Andrew K Gormley; Ivan S Yuhanna; Sherri Osborne-Lawrence; Linda L Gibson; Lisa Hahner; Ralph V Shohet; Steven Black; Jane E Salmon; David Samols; David R Karp; Gail D Thomas; Philip W Shaul
Journal:  Circ Res       Date:  2005-11-03       Impact factor: 17.367

8.  Tyrosine Kinase SYK Licenses MyD88 Adaptor Protein to Instigate IL-1α-Mediated Inflammatory Disease.

Authors:  Prajwal Gurung; Gaofeng Fan; John R Lukens; Peter Vogel; Nicholas K Tonks; Thirumala-Devi Kanneganti
Journal:  Immunity       Date:  2017-04-11       Impact factor: 31.745

9.  Plasma Biomarkers of Inflammation and Angiogenesis Predict Cerebral Cavernous Malformation Symptomatic Hemorrhage or Lesional Growth.

Authors:  Romuald Girard; Hussein A Zeineddine; Janne Koskimäki; Maged D Fam; Ying Cao; Changbin Shi; Thomas Moore; Rhonda Lightle; Agnieszka Stadnik; Kiranj Chaudagar; Sean Polster; Robert Shenkar; Ryan Duggan; David Leclerc; Kevin J Whitehead; Dean Y Li; Issam A Awad
Journal:  Circ Res       Date:  2018-05-02       Impact factor: 17.367

10.  Role of angiopoietin-2 in adaptive tumor resistance to VEGF signaling blockade.

Authors:  Nicolò Rigamonti; Ece Kadioglu; Ioanna Keklikoglou; Céline Wyser Rmili; Ching Ching Leow; Michele De Palma
Journal:  Cell Rep       Date:  2014-07-31       Impact factor: 9.423

View more
  4 in total

1.  Circulating Plasma miRNA Homologs in Mice and Humans Reflect Familial Cerebral Cavernous Malformation Disease.

Authors:  Abhinav Srinath; Ying Li; Romuald Girard; Issam A Awad; Sharbel G Romanos; Bingqing Xie; Chang Chen; Yan Li; Thomas Moore; Dehua Bi; Je Yeong Sone; Rhonda Lightle; Nick Hobson; Dongdong Zhang; Janne Koskimäki; Le Shen; Sara McCurdy; Catherine Chinhchu Lai; Agnieszka Stadnik; Kristina Piedad; Julián Carrión-Penagos; Abdallah Shkoukani; Daniel Snellings; Robert Shenkar; Dinanath Sulakhe; Yuan Ji; Miguel A Lopez-Ramirez; Mark L Kahn; Douglas A Marchuk; Mark H Ginsberg
Journal:  Transl Stroke Res       Date:  2022-06-17       Impact factor: 6.829

2.  Transcriptome Analysis Reveals Altered Expression of Genes Involved in Hypoxia, Inflammation and Immune Regulation in Pdcd10-Depleted Mouse Endothelial Cells.

Authors:  Carmela Fusco; Grazia Nardella; Lucio Di Filippo; Elisabetta Dejana; Davide Cacchiarelli; Antonio Petracca; Lucia Micale; Matteo Malinverno; Marco Castori
Journal:  Genes (Basel)       Date:  2022-05-27       Impact factor: 4.141

3.  CCM2-deficient endothelial cells undergo a ROCK-dependent reprogramming into senescence-associated secretory phenotype.

Authors:  Corinne Albiges-Rizo; Hans Van Oosterwyck; Eva Faurobert; Daphné Raphaëlle Vannier; Apeksha Shapeti; Florent Chuffart; Emmanuelle Planus; Sandra Manet; Paul Rivier; Olivier Destaing
Journal:  Angiogenesis       Date:  2021-08-03       Impact factor: 9.596

4.  A novel insight into differential expression profiles of sporadic cerebral cavernous malformation patients with different symptoms.

Authors:  Hilal Eren Gozel; Kıvanç Kök; Fatma Ozlen; Cihan Isler; Sadrettin Pence
Journal:  Sci Rep       Date:  2021-09-29       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.